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Summary.-The human hepatoma cell line, PLC/PRF/5, was shown to produce
hepatitis B surface antigen (HBSAg). Immunologically reactive material was present
in the supernatant tissue culture medium in significant amounts, and was associated
with spherical particles approximately 20 nm in diameter. The rate of antigen
production by the cells was estimated at500 ng/day/106 cells by reference to a purified
HBSAg standard. All immunological activity was neutralized by specific antibody
and the subtype was ad. The studies reported here broaden the scope of investi-
gations on both the in vitro production of HB,Ag and the association between this
antigen and primary liver cancer.
THE CORRELATION between hepatitis
B surface antigen (HBsAg) and serum
hepatitis has led to extensive research
aimed at finding an in vitro system for the
study of hepatitis B virus (HBV). A
number of reports have appeared on the
propagation of the virus in human liver
cell and organ cultures (review by Zucker-
man, 1975). After HBVr infection, pro-
gressive changes in the cells have been
noted and supernatant culture fluid could
be passaged once or twice, but the short-
term nature of the experiments and the
lack of a constant source of tissue culture
material has failed to provide, as yet, a
standardized in vitro system for the study
of this virus. Coyne, Blumberg and
Millman (1971), using a different approach,
cultured liver tissue from patients with
HB,Ag in their blood, and measured the
antigen in the tissue culture fluid from 2
out of 23 separate culture preparations.
Panouse-Perrin et al. (1973) inoculated a
human hepatic cell line with HBSAg-
containing serum, and reported the repli-
cation of 25-27 nm particles, similar to
the internal component of the Dane
particle, through 14 passages in tissue
culture. However, radioimmunoassays
(RIA) for HBsAg were negative. Hadzi-
yannis (1975) detected hepatitis B core
antigen (HBcAg) in liver slices taken from
a patient with liver cell carcinoma and
cirrhosis. The antigen was present in the
cirrhotic tissue but not in the malignant
cells. A human hepatoma cell line (Pro-
zesky, Brits and Grabow, 1973) has been
tested for the presence of HBsAg, with
negative results, and all attempts to
inoculate the cultures with infectious
material have shown no evidence of virus
replication (Prozesky, personal communi-
cation).
The development of cell lines, either
from normal human liver or hepatoma,
still remains one possible means of supply-
ing a constant source of material which
will either support the replication of HBYT
or produce, de noro, antigens related to the
virus. In view of the clinical association
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between HB,Ag and primary liver cancer
(Vogel et al., 1970; Kew et al., 1974), and
since the PLC/PRF/5 cell line was derived
from a patient with primary liver cancer
whose blood had circulating HB,Ag
(Alexander et al., 1976) we tested this in
vitro system for HBsAg reactivity. We
have shown that this cell line produces
HBsAg in significant amounts and that the
antigen is similar to clinically derived
material.
MATERIALS AND METHODS
(1) Cell cultures and culturefluids
All cells were cultured in 25-cm2 flasks
(Falcon Plastics). Growth medium (5 ml/
flask) was Eagle's minimum essential medium
containing 10% foetal bovine serum (Gibco)
and 100 ,ug/ml each of penicillin and strepto-
mycin. The PLC/PRF/5 hepatoma cells,
which have been in continuous culture for
30 months, resemble hepatocytes and
have a doubling time of 35 to 40 h in
vitro. Ultrastructural examination has re-
vealed no virus-like particles in these cells.
As controls, both fresh growth medium and
culture fluids harvested from other estab-
lished human tumour cell lines were used.
The control cell cultures included a carcinoma
of the oesophagus (Bey et al., 1976), a sar-
coma (Alexander et al., 1976) and two
lymphomas, Raji and EB3 (Epstein, 1970).
Culture medium was harvested from the
hepatoma and control cultures at various
intervals. Hepatoma cells, mechanically
scraped from the flasks, were disrupted by 4
cycles of freezing and thawing. All culture
fluids and cell suspensions were clarified by
centrifugation at 3000 g for 30 min prior to
assay.
(2) HBsAg detection
Solid phase RIA and passive reverse
haemagglutination techniques were used
(Abbott Laboratories, U.S.A., Ausria 11 and
Hepnosticon; Burroughs Wellcome, Hepa-
test). RIA-negative results had count rates
less than 0-3%o of the radioactivity used. In
order to compare results among samples
assayed on different days the following
procedure was employed:- positivity (P) was
accorded to those samples having count rates
per minute at least 5 standard deviations
(s.d.) above the mean value (N) established
for 7 negative controls (Ling and Overby,
1972). The cut-off value for the test series
was 2-1 x N, and this factor is ample to
allow for an increase of > 5 s.d. above
the N value (Abbott Laboratories). Hence,
positive results were computed from the
formula P/N > 2-1. Known positive and
negative sera were supplied by the manu-
facturers of the test kits. In addition, 5 sera
from cases of proven viral hepatitis were
included as positive controls.
Quantitative analyses.-For this purpose
dilutions were made from an HBSAg standard
of known concentration (1000 jtg/ml, ad
serotype, a gift from Dr Overby). Only
dilutions containing between 7-8 and 250
ng/ml were used to generate a standard curve,
because at greater concentration the relation-
ship between 1251 ct/min and concentration
was non-linear. The medium in 21 identical
hepatoma cell cultures was renewed on Day 0,
each receiving 5 ml of fresh medium. The
culture fluids from 3 flasks were harvested
separately every day for 6 days, and finally on
the 8th day. The cells from each flask were
suspended by 5-min incubation in 5 ml of
0.125% trypsin in phosphate-buffered saline
containing 0.05% versene. The cells were
pelleted, resuspended in 2 ml of medium, and
counted in a haemocytometer. Each super-
natant was assayed in triplicate, both
undiluted and after ten-fold dilution.
(3) Preparation of culture medium for immune
electron microscopy
Aneutralizedammoniumsulphatesolution
was added, to give 5000 saturation, to culture
medium which had been in contact with the
hepatoma cells for 6 days. The pellet
obtained after centrifugation at 5000 g
for 30 min was dissolved in distilled water to
the original culture fluid volume and clarified
by centrifugation at 12,000 g for 20 min.
The supernatant was decanted and concen-
trated five-fold by filtration through an
XM300 filter (Amicon). The concentrated
material was layered on to an equal volume
of a 550 saturated solution of CsCl and
centrifuged at 45,000 rev/min in a SW50 head
for 20 h.
Twenty-five-drop fractions were collected
and dialysed against distilled water. Each
gradient fraction was assayed for HBsAg
reactivity (haemagglutination) and the frac-
tion containing the highest activity wasHBsAg IN HUMAN HEPATOMA CELL LINE
TABLE.-HBsAg Determination by Radtioinmmunoassay of Human Cell Line
Supernatants, Hepatorna Cells and Positive Human Sera
P/N values*
Age o
Source of material
Hepatoma cells
Hepatoma cells supernatant
Hepatoma cells supernatant
Hepatoma cells supernatant
Hepatoma cells supernatant
Hepatoma cells supernatant
Oesophageal carcinoma supernatant
Lvmphoma EB3 supsrnatant
Lymphoma Raji supernatant
Sarcoma supernatant
Control medium
Positive serum 1
2
3
4
5
f supernatant
in days
3
3
4
6
7
4
3
3
4
Unconcentrated
7.5
N.D.
26
40
45-4
60-4
1 5
1.2
1*1
09
1 0
55-6
17-6
4-9
9.9
52 0
10 x Concentrated
44-6
93.4
N.D.t
N.D.
N.D.
-N.D.
I 4
1*1
1*1
1*4
1*5
ct/min experiment cPtN ngi ontrol-P/N >2 -1 taken as positive. ct/mln negateve control
t Not (lone.
incubated for 16 h at 370C with one fifth
volume of rabbit antiserum to HBsAg. The
preparation was negatively stained with 3%0
phosphotungstic acid at pH6. Grids were
viewed in a Philips EM 300 electron micro-
scope.
RESULTS
The table lists the values obtained for
HBsAg reactivity in hepatoma cells and
supernatants and from supernatants of
other human cell lines. Results obtained
from positive sera during the same period
have been included for comparison. The
assays were performed over a period of 4
weeks and, although the age of the
harvested supernatants is listed, the
number of cells in each culture was not
evaluated and the material was harvested
from different culture passages. All posi-
tive results (P/N > 2-1) were confirmed
by passive reverse haemagglutination and
specific neutralization. All the hepatoma
supernatants tested were positive and the
subtype was found to be ad in all cases.
Since the disrupted cells had low activity
compared with unconcentrated culture
fluid, further assays were confined to the
latter onlv.
As HBsAg activity appeared toincrease
35
with the age of the culture medium in
contact with the hepatoma cells, experi-
ments were designed to quantitate these
levels, and the results of one ofthese tests
is depicted in Fig. 1. The antigen in the
supernatant does increase with time and
the levels measured, by reference to the
standard curve, indicate that approxi-
mately 500 ng of HBsAg-reactive material
is produced per day per 106 cells.
Immune electron microscopy (Fig. 2)
showed low-grade clumping of particles
ranging in diameter from 16 to 24 nm,
although the majority were approximately
20 nm in size. These particles are more
or less spherical and there is some evidence
of substructure. The CsCl gradient frac-
tion which had the highest antigen activity
and from which this material was pre-
pared had a buoyant density of between
1-18 and 1-2 g/cm3. We have consistently
found these structures in hepatoma cul-
ture supernatants. No Dane particles or
tubular structures have been seen. All
antigenic activity was precipitated from
the supernatants with 50%o ammonium
sulphate saturation, and by centrifugation
at 200,000g for 4h, but not at 100,000
for 2 h. All activity was retained by
filtration through the XM300 filter.
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2
l0
8
6
4
2
- A
I I I I I I I I
4
DAYS
2
B
6
100
8
200
4
6
x
z
2
HB,A8 ng/ml
Fic. l -Radioimmunoassay ofHBsAq in culture medium harcestedfrom hepatoma cells. 5 ml ofsuper-
natant harvested from each flask. (A) 0 average 125J ct/min/ml recorded firom assav of 3 undtiluted
supernatant samples (1-8 days), * number of cells/flask, average of 3 flasks. (B) 0 average
1251 ct/min/ml for 3 supernatants assayed at lOx clilution ( -8 lays), v 125 ct/min from assay of
serial dilutions of purified HBsAg of known concentration.
DISCUSSION
The PLC/PRF/5 cell line consistently
produces HBsAg at a significant level, and
the antigen has the same characteristics
as material derived from clinical sources.
The table demonstrates that the levels of
HBsAg measured in the supernatant
culture medium are similar to those
measured in serum from strongly anti-
genaemic patients and similar high read-
ings have been obtained from supernatants
tested over 9 months and 20 cell-culture
passages. The consistent production of
HBsAg of this cell line is in contrast to
that in previous in vitro studies, where
transient peak levels were detected follow-
ing superinfection of liver cultures.
Numerous cell lines, both established and
semicontinuous, derived from liver and
other tissues of both human and non-
human origin, have been tested in attempts
to establish an in vitro system for HBV
research (Zuckerman, 1975). The results
reported here demonstrate that the PLC/
PRF/5 cell line provides a laboratory
model for further studies on HBsAg
production.
The estimated rate of HB5Ag produc-
3
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FIG. 2.-Immune electron microscopy of particles isolated from HB.5Ag-positive hepatoma culture
medium. x 200,000.
tion, about 500 ng/106 cells/day (Fig. 1),
raises the question whether all the cells or
only a certain proportion are involved in
antigen synthesis. Cloning experiments
currently in progress should clarify this
point, and the fact that high levels have
been measured over 20 passages indicates
that the culture conditions, at least, have
not selected against anyantigen-producing
cells.
Much of the work on HB5Ag has been
directed towards investigating infective
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properties, and the infectious virus is
believed to be the 42 nm Dane particle
(Dane, Cameron and Briggs, 1970), the
component which, in some cases, contains
DNA of 1-6 x 106 daltons (Robinson,
Clayton and Greenman, 1974). Genetic
material of 'this size can code for the
synthesis ofabout 3 polypeptides, whereas
HB,Ag is more complex (Howard and
Zuckerman, 1974; Dreesman, Hollinger
and Melnick, 1975) and Zuckerman (1974)
has suggested that HBV may be classified
among the viroids. Nevertheless there is
extensive evidence which also indicates
thatalthough HBsAg has characteristics of
infectivity, in many respects the antigen
shares features suggestive of protein poly-
morphism. Blumberg (1973) has defined
both properties as characteristic ofHBsAg,
and hypothesized that there are other
agents with similar properties for which
he has suggested the name " Icron ".
Our investigations on the antigen-reactive
material produced by the hepatoma cells
appear to confirm that HBsAg in vitro
maintains both properties:
(1) the antigen is immunologically
detectable in significant quantities
only in the supernatant culture
medium, and electron microscopy
shows that this activity is associ-
ated with spherical particles
approximately 20 nm in diameter,
(2) no small particles, tubular forms,
Dane particles or any virus-like
structures have been detected by
ultrastructural examination of the
producer cells.
These two characteristics appear to be
mutually exclusive although it could be
postulated that maturation of the particle
associated with the immunological activity
occurs concomitantly with its release from
the cell in the medium.
The PLC/PRF/5 cell line produces
HBsAg without superinfection; therefore
there is an association between genetic
material determining production of the
antigen and the hepatoma cells. This
may parallel the association found between
Epstein-Barr virus and some lymphoma
cell lines (Epstein, Achong and Barr,
1964), and it is of interest that Burkitt
lymphoma cases occur at high frequency
in areas which are geographically similar
to and not too distant from Mozambique,
which has a high primary liver cancer
incidence. However, while EBV produc-
tion diminishes during continuous cell
culture, to date no lessening of HBsAg
production by the hepatoma cells has been
measured. Since in vitro material is now
available for study, it should be possible
to define more clearly the nature of the
association between liver cells and the
genetic material responsible for the con-
tinuous production of HBsAg.
The relationship between HBsAg and
primary liver cancer is less defined than
the relationship between the antigen and
human hepatitis. A causal relationship
has been proposed by Vogel et al. (1970),
who studied the clinical association be-
tween primary liver cancer and circulating
HBsAg in patients in Uganda, and sug-
gested that the tumour may be the end
result of a process beginning with HBV
infection. Although our findings lend
some support to this suggestion, they do
not rule out the possibility that other
agents, biological or chemical, may con-
tribute to the initiation and promotion of
the disease. The association between
hepatoma cells and the production of
HBsAg may be a secondary event whereby
the continued synthesis of antigen is a
consequence of the malignancy, or the
presence of the tumour predisposes the
patient to infection. In any case it is not
clear from previous studies or from our
results why the antigen is produced at all.
Our findings, however, do provide oppor-
tunities for a new experimental approach
to the problem of primary liver cancer.
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